Sex, Drugs & Oral Cancer…what does this mean? Let’s take a closer look at oral cancer to see how sex and drugs play a role in the development. The risk factors for oral cancer are not only the traditional risk factors of tobacco, alcohol, and age, but now there is an increasing prevalence being caused from a sexually transmitted virus, HPV 16. With the new risk factor of HPV, oral cancer is not only affecting older patients, but now younger patients without the traditional risk factors. This means that everyone who walks into your office potentially has a significant risk factor. Just as with other cancers, early diagnosis of oral cancer provides a markedly improved prognosis for the patient. Knowing that early discovery for cancer saves lives, our goal should be to screen every patient. With the changing trends, it is important to have a tool in your arsenal for early discovery. OralID™ is the perfect solution and is being used in some of the top clinics and cancer centers across the nation.
OralID™ is an FDA Cleared medical device for oral cancer (and pre-cancer) screening. Without the need for any rinses, dyes or other consumables, OralID™ uses fluorescence technology that when shined in the mouth causes healthy tissue to fluoresce an apple-green color and suspicious tissue appears dark. If a dark lesion is found, the recommended protocol for screening is to have the patient back in two weeks to reassess the lesion. Normally these lesions will have healed in the follow-up period. If the lesion is still present, then performing an advanced cytology swab (CytID™) or a biopsy (PathID™) is recommended at that point.
In addition to the OralID™, Forward Science provides complimentary diagnostic tests designed for early discovery. The company offers an all-inclusive program, called the ID For Life Program™, that provides not only the OralID™ device for each office, but diagnostic tests, unlimited support, marketing materials, a lifetime warranty, and more. The ID For Life Program™ helps to ensure success in implementing an oral cancer screening protocol in each office.
As oral cancer has continued to rise over the past eight years along with the risk factors now affecting all demographics, we encourage you to join Forward Science and commit to screening each of your patients. By working together, we may play a crucial part in reversing oral cancer trends through early detection. Learn more by visiting www.forwardscience.com.
Forward Science is a privately held biotechnology company based in Houston, Texas. OralID, Forward Science’s flagship product, is an award winning oral cancer screening device that allows clinicians to Shine Light. Save Lives.™ by identifying abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer. With the launch of the ID For Life™ Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life™ Program includes the following in an effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX). SalivaMAX is Forward Science’s latest product offering, which is an FDA Cleared prescription strength rinse for all ranges of xerostomia.